Your browser doesn't support javascript.
loading
SH2B1 variants as potential causes of non-syndromic monogenic obesity in a Brazilian cohort.
da Fonseca, Ana Carolina Proença; Assis, Izadora Sthephanie Silva; Salum, Kaio Cezar Rodrigues; Palhinha, Lohanna; Abreu, Gabriella Medeiros; Zembrzuski, Verônica Marques; Campos Junior, Mario; Nogueira Neto, José Firmino; Mattos, Fernanda Cristina C; Cambraia, Amanda; Rosado, Eliane Lopes; Maya-Monteiro, Clarissa Menezes; Cabello, Pedro Hernán; Carneiro, João Regis Ivar; Bozza, Patrícia T.
Afiliação
  • da Fonseca ACP; Laboratory of Immunopharmacology, Oswaldo Cruz Institute, Oswaldo Cruz Foundation (Fiocruz), 4365 Brazil Avenue, 108 Building - Office 44, Rio de Janeiro, RJ, 21040-360, Brazil. ana.proenca@ioc.fiocruz.br.
  • Assis ISS; Human Genetics Laboratory, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil. ana.proenca@ioc.fiocruz.br.
  • Salum KCR; Laboratory of Immunopharmacology, Oswaldo Cruz Institute, Oswaldo Cruz Foundation (Fiocruz), 4365 Brazil Avenue, 108 Building - Office 44, Rio de Janeiro, RJ, 21040-360, Brazil.
  • Palhinha L; Human Genetics Laboratory, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.
  • Abreu GM; Human Genetics Laboratory, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.
  • Zembrzuski VM; Human Genetic Laboratory, Department of General Biology, Institute of Biology, Federal Fluminense University, Niterói, Brazil.
  • Campos Junior M; Laboratory of Immunopharmacology, Oswaldo Cruz Institute, Oswaldo Cruz Foundation (Fiocruz), 4365 Brazil Avenue, 108 Building - Office 44, Rio de Janeiro, RJ, 21040-360, Brazil.
  • Nogueira Neto JF; Human Genetics Laboratory, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.
  • Mattos FCC; Human Genetics Laboratory, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.
  • Cambraia A; Human Genetics Laboratory, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.
  • Rosado EL; Department of Pathology and Laboratory, Rio de Janeiro State University, Rio de Janeiro, Brazil.
  • Maya-Monteiro CM; Institute of Nutrition Josué de Castro, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.
  • Cabello PH; Human Genetics Laboratory, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.
  • Carneiro JRI; Institute of Nutrition Josué de Castro, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.
  • Bozza PT; Laboratory of Immunopharmacology, Oswaldo Cruz Institute, Oswaldo Cruz Foundation (Fiocruz), 4365 Brazil Avenue, 108 Building - Office 44, Rio de Janeiro, RJ, 21040-360, Brazil.
Eat Weight Disord ; 27(8): 3665-3674, 2022 Dec.
Article em En | MEDLINE | ID: mdl-36436143
PURPOSE: SH2B1 gene encodes an important adaptor protein to receptor tyrosine kinases or cytokine receptors associated with Janus kinases. This gene has been associated with the structural and functional modulation of neurons and other cells, and impacts on energy and glucose homeostasis. Several studies suggested that alterations in this gene are strong candidates for the development of obesity. However, only a few studies have screened SH2B1 point variants in individuals with obesity. Therefore, the aim of this study was to investigate the prevalence of SH2B1 variants in a Brazilian cohort of patients with severe obesity and candidates to bariatric surgery. METHODS: The cohort comprised 122 individuals with severe obesity, who developed this phenotype during childhood. As controls, 100 normal-weight individuals were included. The coding region of SH2B1 gene was screened by Sanger sequencing. RESULTS: A total of eight variants were identified in SH2B1, of which p.(Val345Met) and p.(Arg630Gln) variants were rare and predicted as potentially pathogenic by the in the silico algorithms used in this study. The p.(Val345Met) was not found in either the control group or in publicly available databases. This variant was identified in a female patient with severe obesity, metabolic syndrome and hyperglycemia. The p.(Arg630Gln) was also absent in our control group, but it was reported in gnomAD with an extremely low frequency. This variant was observed in a female patient with morbid obesity, metabolic syndrome, hypertension and severe binge-eating disorder. CONCLUSION: Our study reported for the first time two rare and potentially pathogenic variants in Brazilian patients with severe obesity. Further functional studies will be necessary to confirm and elucidate the impact of these variants on SH2B1 protein function and stability, and their impact on energetic metabolism. LEVEL OF EVIDENCE: Level V, cross-sectional descriptive study.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Obesidade Mórbida / Síndrome Metabólica Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Female / Humans País/Região como assunto: America do sul / Brasil Idioma: En Revista: Eat Weight Disord Assunto da revista: GASTROENTEROLOGIA / METABOLISMO Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Brasil País de publicação: Alemanha

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Obesidade Mórbida / Síndrome Metabólica Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Female / Humans País/Região como assunto: America do sul / Brasil Idioma: En Revista: Eat Weight Disord Assunto da revista: GASTROENTEROLOGIA / METABOLISMO Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Brasil País de publicação: Alemanha